Danielle Belgrave is the Vice President of AI and Machine Learning at GSK, where she focuses on building frontier AI to accelerate scientific discovery. Her goal is to help build a future where AI fundamentally changes how science is done, particularly in healthcare and biology.
With over two decades of experience, Belgrave has worked at the intersection of AI, biology, and medicine across academia, Microsoft Research, Google DeepMind, and GSK.